| Financial Year |
March 31 2023 |
| Monetary Funds |
679,250,512.19 |
| Held-for-trading Financial Assets |
254,084.54 |
| Notes Receivable |
-- |
| Accounts Receivable |
108,602,997.01 |
| Advances to Suppliers |
12,625,327.04 |
| Other Receivables |
5,190,801.22 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,189,938,106.61 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
2,354,973.14 |
| Total Current Assets |
1,999,521,116.25 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
15,000,000.00 |
| Investment Properties |
-- |
| Fixed Assetes |
1,574,207,519.88 |
| Under-construction Projects |
41,333,915.72 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
413,381,243.12 |
| R&D expenses |
-- |
| Goodwill |
237,710,834.09 |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
35,496,178.83 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
2,478,279,691.64 |
| Total Assets |
4,477,800,807.89 |
| Short-Term Loans |
25,022,260.27 |
| Trading Financial liabilities |
-- |
| Notes Payable |
101,808,841.20 |
| Accounts Payable |
224,688,646.86 |
| Accounts Received In Advance |
273,841.67 |
| Employee Compensation Payable |
18,331,063.53 |
| Taxes Payable |
69,219,287.57 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
82,199,140.25 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
6,155,528.39 |
| Sub-Total of Current Liabilities |
575,719,969.84 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
107,760,606.56 |
| Total Liabilities |
683,480,576.40 |
| Paid-In Capital(Or Share Stock) |
479,463,409.00 |
| Capital Surplus |
1,573,008,469.04 |
| Surplus Reserve |
197,110,528.49 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,515,261,757.37 |
| Minority Stockholder's Interest |
29,476,067.59 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,764,844,163.90 |
| Owner's Equity（Stockholder's Equity） |
3,794,320,231.49 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,477,800,807.89 |
